Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Centre, Single-blind, Randomized, Two-part, 6-way Cross-over Study to Investigate the Individual Bioequivalence of Gabasandoz® Relative to Neurontin® in Healthy Volunteers.

NCT01821235 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT01821235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01821235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Centre, Single-blind, Randomized, Two-part, 6-way Cross-over Study to Investigate the Individual Bioequivalence of Gabasandoz® Relative to Neurontin® in Healthy Volunteers.
Lead sponsor
University Hospital, Ghent
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2013
Completion date
November 30, 2013
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy and neuropathic pain